94 related articles for article (PubMed ID: 17726153)
1. Adoptive transfer of murine syngeneic graft-vs.-host disease by CD4+ T cells.
Bryson JS; Jennings CD; Brandon JA; Perez J; Caywood BE; Kaplan AM
J Leukoc Biol; 2007 Dec; 82(6):1393-400. PubMed ID: 17726153
[TBL] [Abstract][Full Text] [Related]
2. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets.
Hess AD; Fischer AC; Beschorner WE
J Immunol; 1990 Jul; 145(2):526-33. PubMed ID: 1973185
[TBL] [Abstract][Full Text] [Related]
3. Induction of murine syngeneic graft-versus-host disease by cells of recipient origin.
Brandon JA; Jennings CD; Perez J; Caywood B; Alapat D; Kaplan AM; Bryson JS
Transplantation; 2007 Jun; 83(12):1620-7. PubMed ID: 17589346
[TBL] [Abstract][Full Text] [Related]
4. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.
Flanagan DL; Jennings CD; Bryson JS
J Immunol; 1999 Aug; 163(3):1170-7. PubMed ID: 10415011
[TBL] [Abstract][Full Text] [Related]
5. Murine syngeneic graft-versus-host disease is responsive to broad-spectrum antibiotic therapy.
Brandon JA; Jennings CD; Kaplan AM; Bryson JS
J Immunol; 2011 Mar; 186(6):3726-34. PubMed ID: 21296982
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression.
Fischer AC; Ruvolo PP; Burt R; Horwitz LR; Bright EC; Hess JM; Beschorner WE; Hess AD
J Immunol; 1995 Apr; 154(8):3713-25. PubMed ID: 7706714
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
Ohajekwe OA; James T; Hardy MA; Oluwole SF
Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
[TBL] [Abstract][Full Text] [Related]
8. Rejection of an MHC class II negative tumor following induction of murine syngeneic graft-versus-host disease.
Bryson JS; Jennings CD; Lowery DM; Carlson SL; Pflugh DL; Caywood BE; Kaplan AM
Bone Marrow Transplant; 1999 Feb; 23(4):363-72. PubMed ID: 10100580
[TBL] [Abstract][Full Text] [Related]
9. Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
Hess AD; Fischer AC; Horwitz L; Bright EC; Laulis MK
J Immunol; 1994 Jul; 153(1):400-11. PubMed ID: 8207251
[TBL] [Abstract][Full Text] [Related]
10. Induction of syngeneic graft-versus-host disease in LPS hyporesponsive C3H/HeJ mice.
Flanagan DL; Gross R; Jennings CD; Caywood BE; Goes S; Kaplan AM; Bryson JS
J Leukoc Biol; 2001 Dec; 70(6):873-80. PubMed ID: 11739549
[TBL] [Abstract][Full Text] [Related]
11. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
Fischer AC; Laulis MK; Horwitz L; Beschorner WE; Hess A
J Immunol; 1989 Aug; 143(3):827-32. PubMed ID: 2526175
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin A-induced autoimmune disease in mice.
Bucy RP; Xu XY; Li J; Huang G
J Immunol; 1993 Jul; 151(2):1039-50. PubMed ID: 8335890
[TBL] [Abstract][Full Text] [Related]
13. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
Ewing P; Miklos S; Olkiewicz KM; Müller G; Andreesen R; Holler E; Cooke KR; Hildebrandt GC
Exp Hematol; 2007 Jan; 35(1):155-63. PubMed ID: 17198884
[TBL] [Abstract][Full Text] [Related]
14. In vivo reactivity of T cell clones isolated from mice with syngeneic graft-versus-host disease.
Bryson JS; Lake-Bullock H; Pflugh DL; Jennings CD; Stuart PM; Caywood BE; Kaplan AM
Transplantation; 1995 Jul; 60(2):171-8. PubMed ID: 7624959
[TBL] [Abstract][Full Text] [Related]
15. Anti-IL-23p19 therapy inhibits the adoptive transfer of syngeneic graft-versus-host disease.
Brandon JA; Jennings CD; Kaplan AM; Bryson JS
Cytokine; 2013 Mar; 61(3):732-5. PubMed ID: 23402791
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune-mediated vasculopathy.
Chen W; Thoburn CJ; Miura Y; Sommer M; Hruban R; Qian Z; Baldwin W; Hess AD
Clin Immunol; 2001 Jul; 100(1):57-70. PubMed ID: 11414746
[TBL] [Abstract][Full Text] [Related]
17. Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease.
Brandon JA; Perez J; Jennings CD; Cohen DA; Sindhava VJ; Bondada S; Kaplan AM; Bryson JS
Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G602-13. PubMed ID: 20634434
[TBL] [Abstract][Full Text] [Related]
18. Thy1+ bone marrow cells regulate the induction of murine syngeneic graft-versus-host disease.
Bryson JS; Jennings CD; Caywood BE; Kaplan AM
Transplantation; 1993 Oct; 56(4):941-5. PubMed ID: 8105571
[TBL] [Abstract][Full Text] [Related]
19. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
Thoburn CJ; Miura Y; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Sep; 10(9):591-603. PubMed ID: 15319771
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide participates in the intestinal pathology associated with murine syngeneic graft-versus-host disease.
Flanagan DM; Jennings CD; Goes SW; Caywood BE; Gross R; Kaplan AM; Bryson JS
J Leukoc Biol; 2002 Oct; 72(4):762-8. PubMed ID: 12377946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
